Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

Jordi Llaneras, Mar Riveiro-Barciela, Sabela Lens, Moisés Diago, Alba Cachero, Javier García-Samaniego, Isabel Conde, Ana Arencibia, Juan Arenas, Francisco Gea, Xavier Torras, José Luis Calleja, José Antonio Carrión, Inmaculada Fernández, Rosa María Morillas, José Miguel Rosales, Isabel Carmona, Conrado Fernández-Rodríguez, Manuel Hernández-Guerra, Susana LlerenaVanesa Bernal, Juan Turnes, Jesús M. González-Santiago, Silvia Montoliu, Blanca Figueruela, Ester Badia, Manuel Delgado, Miguel Fernández-Bermejo, Mercedes Iñarrairaegui, Juan Manuel Pascasio, Rafael Esteban, Zoe Mariño, Maria Buti

Research output: Contribution to journalArticleResearch

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs'. Together they form a unique fingerprint.

Medicine & Life Sciences